Maintenance of eupnea of in situ and in vivo rats following riluzole: a blocker of persistent sodium channels

Respir Physiol Neurobiol. 2007 Jan 15;155(1):97-100. doi: 10.1016/j.resp.2006.04.018. Epub 2006 Jul 1.

Abstract

We have proposed a "switching" concept for the neurogenesis of breathing in which rhythm generation by a pontomedullary neuronal circuit for eupnea may be switched to a medullary pacemaker system for gasping. This switch involves activation of conductances through persistent sodium channels. Based upon this proposal, eupnea should continue following a blockade of persistent sodium channels. In situ preparations of the decerebrate, juvenile rat were studied in normocapnia, hypocapnia and hypercapnia. Regardless of the level of CO(2) drive, riluzole (1-10 microM), a blocker of persistent sodium channels, caused increases in the frequency and reductions in peak integrated phrenic height. Even 20 microM of riluzole, a concentration four-fold higher than that which eliminates gasping, did not cause a cessation of phrenic discharge. In conscious, rats breathing continued unabated following intravenous administrations of 3-9 mgkg(-1) of riluzole. These administrations did cause sedation. We conclude that conductance through persistent sodium channels plays little role in the neurogenesis of eupnea.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbon Dioxide / blood
  • Decerebrate State / physiopathology
  • Electromyography
  • Hypercapnia / blood
  • Hypoxia / physiopathology
  • Injections, Intravenous
  • Male
  • Medulla Oblongata / drug effects
  • Medulla Oblongata / physiology
  • Phrenic Nerve / physiopathology
  • Rats
  • Respiratory Mechanics / drug effects*
  • Respiratory Mechanics / physiology*
  • Respiratory Muscles / physiology
  • Riluzole / administration & dosage
  • Riluzole / pharmacology*
  • Sodium Channel Blockers / administration & dosage
  • Sodium Channel Blockers / pharmacology*

Substances

  • Sodium Channel Blockers
  • Carbon Dioxide
  • Riluzole